Icon

PEMFEXY (nda209472)- (500MG/20ML (25MG/ML))

PEMETREXED EAGLE PHARMS
500MG/20ML (25MG/ML)
Yes Yes
2036-Feb-19 Expired
None None
None No
PEMFEXY is a folate analog metabolic inhibitor indicated for: • in combination with cisplatin for the initial treatment of patients with locally advanced or metastatic non-squamous, non-small cell lung cancer (NSCLC). • as a single agent for the maintenance treatment of patients with locally advanced or metastatic non-squamous NSCLC whose disease has not progressed after four cycles of platinum-based first-line chemotherapy. • as a single agent for the treatment of patients with recurrent, metastatic non-squamous NSCLC after prior chemotherapy.
0 0 0
Total Other Developers None
Drugs with Suitability No
500MG/20ML (25MG/ML) ** ** - - -
NDA Sales Available Total Generic Sales Available
Yes 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search





Expired
to
Expired
to


Please contact contact@researchdelta.com to get more details.